Nav: Home

Parasite strain-specific factors determine malaria disease severity

June 21, 2017

Scientists have uncovered strain-specific differences between malaria parasites that are linked to their potential to cause illness in humans, which could have important implications for antimalarial vaccine trials currently underway. According to World Health Organization estimates, there were 212 million cases of malaria worldwide in 2015, and 429,000 deaths from the mosquito-borne condition. During the initial stages of malaria infection, immature forms of the parasite called sporozoites invade liver cells, where they mature and multiply for six to seven days before releasing several thousand progeny into the bloodstream, causing clinical symptoms. Not all infections result in life-threatening anemia and organ failure, which is why scientists have long debated whether host or parasite factors ultimately dictate disease outcomes in patients. Here, Matthew McCall and colleagues carried out controlled malaria infections in 23 healthy human volunteers, finding that three geographic and genetically diverse forms of the parasite each demonstrated a distinct ability to infect liver cells. Interestingly, the researchers observed the degree of infection in human liver cells growing in culture was closely correlated with parasite loads in the bloodstream. All study participants were treated with antimalarial drugs and subsequently recovered, though some strains caused more severe symptoms, including fever and malaise. McCall et al. say the variability among parasite types indicates that future challenge studies for malaria vaccines should use multiple strains, to more accurately predict the efficacy of candidates in development. They also note that the infectivity of the different parasite strains may vary in populations who may have previously been exposed to malaria, and therefore, further investigation in endemic settings is needed.

American Association for the Advancement of Science

Related Malaria Articles:

Could there be a 'social vaccine' for malaria?
Malaria is a global killer and a world health concern.
Transgenic plants against malaria
Scientists have discovered a gene that allows to double the production of artemisinin in the Artemisia annua plant.
Fighting malaria through metabolism
EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite.
Should we commit to eradicate malaria worldwide?
Should we commit to eradicate malaria worldwide, asks a debate article published by The BMJ today?
Investigational malaria vaccine shows considerable protection in adults in malaria season
An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria -- the deadliest form of the disease -- for the duration of the malaria season, according to new findings published in the Feb.
Why malaria mosquitoes like people with malaria
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria.
Malaria superbugs threaten global malaria control
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published today in The Lancet Infectious Diseases.
Considering cattle could help eliminate malaria in India
The goal of eliminating malaria in countries like India could be more achievable if mosquito-control efforts take into account the relationship between mosquitoes and cattle, according to an international team of researchers.
Seasonal malaria chemoprevention in Senegalese children lowers overall malaria burden
Giving preventive antimalarial drugs to children up to age 10 during active malaria season reduced the cases of malaria in that age group and lowered the malaria incidence in adults, according to a randomized trial carried out in Senegal and published in PLOS Medicine by researchers from the Université Cheikh Anta Diop, Senegal, the London School of Hygiene & Tropical Medicine, UK, and other collaborators.
How malaria fools our immune system
OIST researchers reconstruct the 3-D structure of a malaria protein in combination with human antibodies.

Related Malaria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".